Molecular imaging in oncology: The acceptance of PET/CT and the emergence of MR/PET imaging

European Radiology

Volumn 21, Issue 3, 2011, Pages 548-554

  Schiepers, Christiaan ^a   Dahlbom, Magnus ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

CT Computed tomography; FDG 18F Fluoro deoxy glucose; MRI Magnetic Resonance Imaging; MRS Magnetic Resonance Spectroscopy; PET Positron Emission Tomography; Staging of Cancer; Therapy Monitoring

Indexed keywords

CONTRAST MEDIUM; FLUORODEOXYGLUCOSE F 18;

CLINICAL ASSESSMENT TOOL; CLINICAL PRACTICE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; MOLECULAR IMAGING; MULTIDETECTOR COMPUTED TOMOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; ONCOLOGY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIATION DOSE; REVIEW; SPECTRAL SENSITIVITY;

HUMANS; MAGNETIC RESONANCE IMAGING; MEDICAL ONCOLOGY; MOLECULAR IMAGING; NEOPLASMS; PHYSICIAN'S PRACTICE PATTERNS; POSITRON-EMISSION TOMOGRAPHY; SUBTRACTION TECHNIQUE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 79751534354     PISSN: 09387994     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00330-010-2033-y     Document Type: Review

References (69)

1. A Jemal R Siegel E Ward, et al. 2009 Cancer statistics, 2009 CA Cancer J Clin 59 225 249 10.3322/caac.20006 19474385
2. C Schiepers CK Hoh 1998 Positron emission tomography as a diagnostic tool in oncology Eur Radiol 8 1481 1494 1:STN:280:DyaK1M%2FntVemsQ%3D%3D 10.1007/s003300050579 9853241 (Pubitemid 128662821)
3. DW Townsend SR Cherry 2001 Combining anatomy and function: the path to true image fusion Eur Radiol 11 1968 1974 1:STN:280:DC%2BD3MnkvValsA%3D%3D 10.1007/s003300101007 11702130 (Pubitemid 32936900)
4. BJ Pichler A Kolb T Nagele, et al. 2010 PET/MRI: paving the way for the next generation of clinical multimodality imaging applications J Nucl Med 51 333 336 10.2967/jnumed.109.061853 20150252
5. BA Siegel F Dehdashti 2005 Oncologic PET/CT: current status and controversies Eur Radiol 15 Suppl 4 D127 132 16479662
6. T Denecke B Rau KT Hoffmann, et al. 2005 Comparison of CT, MRI and FDG-PET in response prediction of patients with locally advanced rectal cancer after multimodal preoperative therapy: is there a benefit in using functional imaging? Eur Radiol 15 1658 1666 1:STN:280:DC%2BD2Mzns1emtg%3D%3D 10.1007/s00330-005-2658-4 15806369 (Pubitemid 41102362)
7. GP Schmidt AR Haug SO Schoenberg, et al. 2006 Whole-body MRI and PET-CT in the management of cancer patients Eur Radiol 16 1216 1225 10.1007/s00330-006-0183-8 16538426 (Pubitemid 43834707)
8. A Lakkaraju CN Patel KM Bradley, et al. 2010 PET/CT in primary musculoskeletal tumours: a step forward Eur Radiol 20 2959 2972 1:STN:280:DC%2BC3cbmtFGluw%3D%3D 10.1007/s00330-010-1862-z 20577880
9. SS Gambhir J Czernin J Schwimmer, et al. 2001 A tabulated summary of the FDG PET literature J Nucl Med 42 1S 93S 1:STN:280:DC%2BD3Mvjs1Wgtw%3D%3D 11483694 (Pubitemid 32423895)
10. M Dahlbom EJ Hoffman CK Hoh, et al. 1992 Whole-body positron emission tomography. 1. Methods and performance characteristics J Nucl Med 33 1191 1199 1:STN:280:DyaK383osVejsA%3D%3D 1597738
11. GW Goerres C Burger MW Schwitter, et al. 2003 PET/CT of the abdomen: optimizing the patient breathing pattern Eur Radiol 13 734 739 10.1007/s00330-002-1720-8 12664111 (Pubitemid 36869357)
12. R de Juan B Seifert T Berthold, et al. 2004 Clinical evaluation of a breathing protocol for PET/CT Eur Radiol 14 1118 1123 10.1007/s00330-003-2174-3 14676976 (Pubitemid 38787257)
13. PE Kinahan BH Hasegawa T Beyer 2003 X-ray-based attenuation correction for positron emission tomography/computed tomography scanners Semin Nucl Med 33 166 179 10.1053/snuc.2003.127307 12931319 (Pubitemid 36859496)
14. EM Kamel C Burger A Buck, et al. 2003 Impact of metallic dental implants on CT-based attenuation correction in a combined PET/CT scanner Eur Radiol 13 724 728 12664109 (Pubitemid 36790553)
15. GK von Schulthess HC Steinert TF Hany 2006 Integrated PET/CT: current applications and future directions Radiology 238 405 422 10.1148/radiol. 2382041977 (Pubitemid 43134354)
16. TM Blodgett CC Meltzer DW Townsend 2007 PET/CT: form and function Radiology 242 360 385 10.1148/radiol.2422051113 17255408 (Pubitemid 46150968)
17. LS Freudenberg SJ Rosenbaum T Beyer, et al. 2010 PET versus PET/CT dual-modality imaging in evaluation of lung cancer Thorac Surg Clin 20 25 30 10.1016/j.thorsurg.2009.12.003 20378058
18. PJ Ell 2006 The contribution of PET/CT to improved patient management Br J Radiol 79 32 36 1:STN:280:DC%2BD28%2Fjt1KksA%3D%3D 10.1259/bjr/18454286 16421402 (Pubitemid 43159313)
19. L Blomqvist MR Torkzad 2003 Whole-body imaging with MRI or PET/CT: the future for single-modality imaging in oncology? JAMA 290 3248 3249 1:CAS:528:DC%2BD2cXjvFeh 10.1001/jama.290.24.3248 14693879 (Pubitemid 38020688)
20. VV Patil ZJ Wang RA Sollitto, et al. 2009 18F-FDG PET/CT of transitional cell carcinoma AJR Am J Roentgenol 193 W497 504 10.2214/AJR.08.1945 19933624
21. DA Podoloff HA Macapinlac 2007 PET and PET/CT in management of the lymphomas Radiol Clin North Am 45 689 696 10.1016/j.rcl.2007.05.008 17706533 vii (Pubitemid 47238393)
22. P Prakash CG Cronin MA Blake 2010 Role of PET/CT in ovarian cancer AJR Am J Roentgenol 194 W464 470 10.2214/AJR.09.3843 20489063
23. RL Wahl 2004 Why nearly all PET of abdominal and pelvic cancers will be performed as PET/CT J Nucl Med 45 Suppl 1 82S 95S 14736839
24. D Lardinois W Weder TF Hany, et al. 2003 Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography N Engl J Med 348 2500 2507 10.1056/NEJMoa022136 12815135 (Pubitemid 36706537)
25. GW Goerres SC Michel MK Fehr, et al. 2003 Follow-up of women with breast cancer: comparison between MRI and FDG PET Eur Radiol 13 1635 1644 10.1007/s00330-002-1720-8 12835979 (Pubitemid 36869357)
26. BJ Fueger WA Weber A Quon, et al. 2005 Performance of 2-deoxy-2-[F-18]fluoro-D-glucose positron emission tomography and integrated PET/CT in restaged breast cancer patients Mol Imaging Biol 7 369 376 10.1007/s11307-005-0013-4 16220355 (Pubitemid 44193414)
27. L Radan S Ben-Haim R Bar-Shalom, et al. 2006 The role of FDG-PET/CT in suspected recurrence of breast cancer Cancer 107 2545 2551 10.1002/cncr.22292 17063499 (Pubitemid 44845606)
28. P Veit-Haibach G Antoch T Beyer, et al. 2007 FDG-PET/CT in restaging of patients with recurrent breast cancer: possible impact on staging and therapy Br J Radiol 80 508 515 1:STN:280:DC%2BD2svosFClsw%3D%3D 10.1259/bjr/17395663 17537758 (Pubitemid 47343078)
29. A Kumar R Kumar V Seenu, et al. 2009 The role of 18F-FDG PET/CT in evaluation of early response to neoadjuvant chemotherapy in patients with locally advanced breast cancer Eur Radiol 19 1347 1357 10.1007/s00330-009-1303-z 19214522
30. C Schiepers 2003 PET/CT in Colorectal Cancer J Nucl Med 44 1804 1805 14602863 (Pubitemid 39663313)
31. S Kinner G Antoch A Bockisch, et al. 2007 Whole-body PET/CT-colonography: a possible new concept for colorectal cancer staging Abdom Imaging 32 606 612 10.1007/s00261-007-9202-8 17387540 (Pubitemid 47594245)
32. GP Schmidt A Baur-Melnyk A Haug, et al. 2009 Whole-body MRI at 1.5 T and 3 T compared with FDG-PET-CT for the detection of tumour recurrence in patients with colorectal cancer Eur Radiol 19 1366 1378 1:STN:280:DC%2BD1MzktFGqsw%3D%3D 10.1007/s00330-008-1289-y 19190917
33. O Schaefer M Langer 2007 Detection of recurrent rectal cancer with CT, MRI and PET/CT Eur Radiol 17 2044 2054 1:STN:280:DC%2BD2svgtFSrsg%3D%3D 10.1007/s00330-007-0613-2 17404742 (Pubitemid 47097462)
34. A Al-Ibraheem A Buck BJ Krause, et al. 2009 Clinical Applications of FDG PET and PET/CT in Head and Neck Cancer J Oncol 2009 208725 19707528
35. R Hustinx G Lucignani 2010 PET/CT in head and neck cancer: an update Eur J Nucl Med Mol Imaging 37 645 651 10.1007/s00259-009-1365-9 20187296
36. DY Yoon HS Hwang SK Chang, et al. 2009 CT, MR, US, 18F-FDG PET/CT, and their combined use for the assessment of cervical lymph node metastases in squamous cell carcinoma of the head and neck Eur Radiol 19 634 642 10.1007/s00330-008-1192-6 18843493
37. K Kitajima K Murakami E Yamasaki, et al. 2008 Performance of FDG-PET/CT for diagnosis of recurrent uterine cervical cancer Eur Radiol 18 2040 2047 10.1007/s00330-008-0979-9 18425518
38. PW Grigsby 2008 The prognostic value of PET and PET/CT in cervical cancer Cancer Imaging 8 146 155 10.1102/1470-7330.2008.0022 18694852
39. EA Kidd BA Siegel F Dehdashti, et al. 2010 Lymph node staging by positron emission tomography in cervical cancer: relationship to prognosis J Clin Oncol 28 2108 2113 10.1200/JCO.2009.25.4151 20308664
40. SH Ng SC Chan TC Yen, et al. 2010 Comprehensive imaging of residual/ recurrent nasopharyngeal carcinoma using whole-body MRI at 3 T compared with FDG-PET-CT Eur Radiol 20 2229 2240 10.1007/s00330-010-1784-9 20393714
41. LS Freudenberg A Frilling H Kuhl, et al. 2007 Dual-modality FDG-PET/CT in follow-up of patients with recurrent iodine-negative differentiated thyroid cancer Eur Radiol 17 3139 3147 10.1007/s00330-007-0682-2 18004607 (Pubitemid 350147679)
42. LS Freudenberg G Antoch W Jentzen, et al. 2004 Value of (124)I-PET/CT in staging of patients with differentiated thyroid cancer Eur Radiol 14 2092 2098 1:STN:280:DC%2BD2crjtVGmtw%3D%3D 10.1007/s00330-004-2350-0 15232708 (Pubitemid 39481183)
43. TS Aukema RA Valdes Olmos MW Wouters, et al. 2010 Utility of preoperative 18F-FDG PET/CT and brain MRI in melanoma patients with palpable lymph node metastases Ann Surg Oncol 17 2773 2778 10.1245/s10434-010-1088-y 20422454
44. H Schoder SM Larson HW Yeung 2004 PET/CT in oncology: integration into clinical management of lymphoma, melanoma, and gastrointestinal malignancies J Nucl Med 45 Suppl 1 72S 81S 14736838
45. K Strobel R Dummer DB Husarik, et al. 2007 High-risk melanoma: accuracy of FDG PET/CT with added CT morphologic information for detection of metastases Radiology 244 566 574 10.1148/radiol.2442061099 17641374 (Pubitemid 47080890)
46. M Allen-Auerbach S de Vos J Czernin 2008 The impact of fluorodeoxyglucose-positron emission tomography in primary staging and patient management in lymphoma patients Radiol Clin North Am 46 199 211 10.1016/j.rcl.2008.03.004 18619376 vii (Pubitemid 351932039)
47. MS Hofman NC Smeeton SC Rankin, et al. 2009 Observer variation in interpreting 18F-FDG PET/CT findings for lymphoma staging J Nucl Med 50 1594 1597 10.2967/jnumed.109.064121 19759113
48. YL Kasamon RJ Jones RL Wahl 2007 Integrating PET and PET/CT into the risk-adapted therapy of lymphoma J Nucl Med 48 Suppl 1 19S 27S 1:CAS:528:DC%2BD2sXitVanu7k%3D 17204717 (Pubitemid 47604939)
49. TC Kwee RM Kwee 2009 Combined FDG-PET/CT for the detection of unknown primary tumors: systematic review and meta-analysis Eur Radiol 19 731 744 10.1007/s00330-008-1194-4 18925401
50. SJ Rosenbaum T Lind G Antoch, et al. 2006 False-positive FDG PET uptake - the role of PET/CT Eur Radiol 16 1054 1065 10.1007/s00330-005-0088-y 16365730
51. CM Costelloe WA Murphy Jr BA Chasen 2009 Musculoskeletal pitfalls in 18F-FDG PET/CT: pictorial review AJR Am J Roentgenol 193 WS1 WS13 10.2214/AJR.07.7138 19696250 Quiz S26-30
52. MC Adams TG Turkington JM Wilson, et al. 2010 A systematic review of the factors affecting accuracy of SUV measurements AJR Am J Roentgenol 195 310 320 10.2214/AJR.10.4923 20651185
53. C Schiepers CK Hoh J Nuyts, et al. 2008 1-11C-acetate kinetics of prostate cancer J Nucl Med 49 206 215 1:CAS:528:DC%2BD1cXivVOltLs%3D 10.2967/jnumed.107.044453 18199613 (Pubitemid 351225658)
54. I Apostolova R Wiemker T Paulus, et al. 2010 Combined correction of recovery effect and motion blur for SUV quantification of solitary pulmonary nodules in FDG PET/CT Eur Radiol 20 1868 1877 10.1007/s00330-010-1747-1 20306084
55. MA Blake BN Setty CG Cronin, et al. 2010 Evaluation of the effects of oral water and low-density barium sulphate suspension on bowel appearance on FDG-PET/CT Eur Radiol 20 157 164 10.1007/s00330-009-1527-y 19680659
56. LF de Geus-Oei D Vriens HW van Laarhoven, et al. 2009 Monitoring and predicting response to therapy with 18F-FDG PET in colorectal cancer: a systematic review J Nucl Med 50 Suppl 1 43S 54S 10.2967/jnumed.108.057224 19403879
57. Jarritt PH, Carson KJ, Hounsell AR et al (2006) The role of PET/CT scanning in radiotherapy planning. Br J Radiol 79 Spec No 1:S27-35 (Pubitemid 44614401)
58. EC Ford J Herman E Yorke, et al. 2009 18F-FDG PET/CT for image-guided and intensity-modulated radiotherapy J Nucl Med 50 1655 1665 10.2967/jnumed.108. 055780 19759099
59. C Messa N Di Muzio M Picchio, et al. 2006 PET/CT and radiotherapy Q J Nucl Med Mol Imaging 50 4 14 1:STN:280:DC%2BD287mvVSgtg%3D%3D 16557199
60. H Minn S Suilamo J Seppala 2010 Impact of PET/CT on planning of radiotherapy in head and neck cancer Q J Nucl Med Mol Imaging 54 521 532 1:STN:280:DC%2BC3cfnslaqtA%3D%3D 20927019
61. TF Budinger 1983 Time-of-flight positron emission tomography: status relative to conventional PET J Nucl Med 24 73 78 1:CAS:528:DyaL3sXmsl2mtw%3D%3D 6336778 (Pubitemid 13190003)
62. R Allemand C Gresset J Vacher 1980 Potential advantages of a cesium fluoride scintillator for a time-of-flight positron camera J Nucl Med 21 153 155 1:CAS:528:DyaL3cXhtlyltrk%3D 6965404 (Pubitemid 10135278)
63. MS Judenhofer HF Wehrl DF Newport, et al. 2008 Simultaneous PET-MRI: a new approach for functional and morphological imaging Nat Med 14 459 465 1:CAS:528:DC%2BD1cXktl2is7k%3D 10.1038/nm1700 18376410 (Pubitemid 351499385)
64. BJ Pichler MS Judenhofer C Catana, et al. 2006 Performance test of an LSO-APD detector in a 7-T MRI scanner for simultaneous PET/MRI J Nucl Med 47 639 647 16595498 (Pubitemid 46768465)
65. BJ Pichler MS Judenhofer HF Wehrl 2008 PET/MRI hybrid imaging: devices and initial results Eur Radiol 18 1077 1086 10.1007/s00330-008-0857-5 18357456
66. A Boss S Bisdas A Kolb, et al. 2010 Hybrid PET/MRI of intracranial masses: initial experiences and comparison to PET/CT J Nucl Med 51 1198 1205 10.2967/jnumed.110.074773 20660388
67. MA Fischer D Nanz T Hany, et al. 2010 Diagnostic accuracy of whole-body MRI/DWI image fusion for detection of malignant tumours: a comparison with PET/CT Eur Radiol 10.1007/s00330-010-1929-x
68. M Hofmann F Steinke V Scheel, et al. 2008 MRI-based attenuation correction for PET/MRI: a novel approach combining pattern recognition and atlas registration J Nucl Med 49 1875 1883 10.2967/jnumed.107.049353 18927326
69. ME Phelps 2000 Inaugural article: positron emission tomography provides molecular imaging of biological processes Proc Natl Acad Sci U S A 97 9226 9233 1:CAS:528:DC%2BD3cXls12ksb8%3D 10.1073/pnas.97.16.9226 10922074 (Pubitemid 30627544)